Skip to main content

Table 3 Lipid biomarkers found in patients’ plasma

From: Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease

Before LIS vs. after LIS

Before BBR plus LIS vs. after BBR plus LIS

After LIS vs. after BBR plus LIS

LPC(20:4)

LPC(18:2)

PC(36:4)

LPC(22:6)

LPC(20:4)

PC(40:9)

LPI(20:4)

LPC(20:5)

 

PC(P-38:5)

LPC(22:6)

 
 

LPI(20:4)

 
 

LPI(18:0)

 
  1. Based on the criteria for the identification of the potential biomarkers, OPLS-DA analysis detected some biomarkers reflecting the therapeutic effect of berberine and lifestyle intervention